HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GSA revised budget for FDA campus consolidation is $80 mil. less than original projection.

This article was originally published in The Rose Sheet

Executive Summary

GSA $80 MIL. COST SCALE-BACK FOR FDA CAMPUS CONSOLIDATION is greeted favorably by House Transportation and Infrastructure Public Buildings and Economic Development Subcommittee Chairman Wayne Gilchrest (R-MD) at a March 6 hearing. "The original cost of the project was considerably larger than the current scope of this project," Gilchrest observed. The revised $810 mil. cost estimate is $80 mil. less than the agency's original $890 mil. projection and significantly less than initial 1990 estimates of $1.4 bil.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS001414

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel